The impact of female gender on bladder cancer-specific death risk after radical cystectomy: a meta-analysis of 27,912 patients

International Urology and Nephrology

Volumn 47, Issue 6, 2015, Pages 951-958

  Liu, Shenghua ^a   Yang, Tian ^a   Na, Rong ^a   Hu, Mengbo ^a   Zhang, Limin ^a   Fu, You ^b   Jiang, Haowen ^a   Ding, Qiang ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Bladder cancer; Cancer specific mortality; Cancer specific survival; Gender; Meta analysis

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CYSTECTOMY; DISEASE SEVERITY; EMBASE; EUROPEAN; FEMALE; GENDER; HUMAN; MEDLINE; META ANALYSIS; NORTH AMERICAN; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PUBLISHING; SAMPLE SIZE; SEX DIFFERENCE; MALE; MORTALITY; PROCEDURES; RISK ASSESSMENT; SEX RATIO; URINARY BLADDER NEOPLASMS;

CYSTECTOMY; FEMALE; HUMANS; MALE; RISK ASSESSMENT; SEX DISTRIBUTION; SEX FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84929961529     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-015-0980-6     Document Type: Article

References (38)

1. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9–29
2. Mungan NA, Aben KK, Schoenberg MP, Visser O, Coebergh JW et al (2000) Gender differences in stage-adjusted bladder cancer survival. Urology 55:876–880
3. Soave A, Dahlem R, Hansen J, Weisbach L, Minner S et al (2015) Gender-specific outcomes of bladder cancer patients: a stage-specific analysis in a contemporary, homogenous radical cystectomy cohort. Eur J Surg Oncol 41:368–377
4. Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H et al (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63:234–241
5. Patel HD, Ball MW, Cohen JE, Kates M, Pierorazio PM et al (2015) Morbidity of urologic surgical procedures: an analysis of rates, risk factors, and outcomes. Urology 85:552–560
6. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558
7. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560
8. Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
9. Otto W, May M, Fritsche HM, Dragun D, Aziz A et al (2012) Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder. Gend Med 9:481–489
10. May M, Burger M, Brookman-May S, Stief CG, Fritsche HM et al (2014) EORTC progression score identifies patients at high risk of cancer-specific mortality after radical cystectomy for secondary muscle-invasive bladder cancer. Clin Genitourin Cancer 12:278–286
11. Fajkovic H, Cha EK, Jeldres C, Robinson BD, Rink M et al (2013) Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis. Eur Urol 64:837–845
12. Messer JC, Shariat SF, Dinney CP, Novara G, Fradet Y et al (2014) Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis. Urology 83:863–867
13. Kluth LA, Rieken M, Xylinas E, Kent M, Rink M et al (2014) Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients. Eur Urol 66:913–919
14. Moschini M, Suardi N, Pellucchi F, Rocchini L, La Croce G et al (2014) Impact of preoperative thrombocytosis on pathological outcomes and survival in patients treated with radical cystectomy for bladder carcinoma. Anticancer Res 34:3225–3230
15. Da SR, Xylinas E, Kluth L, Crivelli JJ, Chrystal J et al (2013) Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy. J Urol 190:487–492
16. Kwon T, Jeong IG, You D, Hong B, Hong JH et al (2014) Long-term oncologic outcomes after radical cystectomy for bladder cancer at a single institution. J Korean Med Sci 29:669–675
17. Tarin TV, Power NE, Ehdaie B, Sfakianos JP, Silberstein JL et al (2012) Lymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity. Eur Urol 61:1025–1030
18. Gore JL, Kwan L, Saigal CS, Litwin MS (2005) Marriage and mortality in bladder carcinoma. Cancer 104:1188–1194
19. Aziz A, Shariat SF, Roghmann F, Brookman-May S, Stief CG et al (2014) Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder - development of a tool for clinical decision-making. BJU Int. doi:10.1111/bju.12984
20. Hermanns T, Bhindi B, Wei Y, Yu J, Noon AP et al (2014) Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder. Br J Cancer 111:444–451
21. Kolla SB, Seth A, Singh MK, Gupta NP, Hemal AK et al (2008) Prognostic significance of Her2/neu overexpression in patients with muscle invasive urinary bladder cancer treated with radical cystectomy. Int Urol Nephrol 40:321–327
22. Fritsche HM, May M, Denzinger S, Otto W, Siegert S et al (2013) Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma. Eur Urol 63:739–744
23. Bostrom PJ, Alkhateeb S, Trottier G, Athanasopoulos PZ, Mirtti T et al (2012) Sex differences in bladder cancer outcomes among smokers with advanced bladder cancer. BJU Int 109:70–76
24. Morikawa T, Kawai T, Abe H, Kume H, Homma Y et al (2013) UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy. Int J Clin Exp Pathol 6:1367–1374
25. Kruger S, Mahnken A, Kausch I, Feller AC (2006) Value of clusterin immunoreactivity as a predictive factor in muscle-invasive urothelial bladder carcinoma. Urology 67:105–109
26. Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H et al (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63:234–241
27. Nieder AM, Lotan Y, Nuss GR, Langston JP, Vyas S et al (2010) Are patients with hematuria appropriately referred to urology? A multi-institutional questionnaire based survey. Urol Oncol 28:500–503
28. Cohn JA, Vekhter B, Lyttle C, Steinberg GD, Large MC (2014) Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation. Cancer 120:555–561
29. Hollenbeck BK, Dunn RL, Ye Z, Hollingsworth JM, Skolarus TA et al (2010) Delays in diagnosis and bladder cancer mortality. Cancer 116:5235–5242
30. Okajima E, Hiramatsu T, Iriya K, Ijuin M, Matsushima S (1975) Effects of sex hormones on development of urinary bladder tumours in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Urol Res 3:73–79
31. Dietrich K, Demidenko E, Schned A, Zens MS, Heaney J et al (2011) Parity, early menopause and the incidence of bladder cancer in women: a case–control study and meta-analysis. Eur J Cancer 47:592–599
32. Cantwell MM, Lacey JJ, Schairer C, Schatzkin A, Michaud DS (2006) Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study. Int J Cancer 119:2398–2401
33. Miyamoto H, Yao JL, Chaux A, Zheng Y, Hsu I et al (2012) Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder. BJU Int 109:1716–1726
34. Hsu I, Yeh CR, Slavin S, Miyamoto H, Netto GJ et al (2014) Estrogen receptor alpha prevents bladder cancer via INPP4B inhibited akt pathway in vitro and in vivo. Oncotarget 5:7917–7935
35. Hsu I, Chuang KL, Slavin S, Da J, Lim WX et al (2014) Suppression of ERbeta signaling via ERbeta knockout or antagonist protects against bladder cancer development. Carcinogenesis 35:651–661
36. Miyamoto H, Yang Z, Chen YT, Ishiguro H, Uemura H et al (2007) Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst 99:558–568
37. Izumi K, Zheng Y, Hsu JW, Chang C, Miyamoto H (2013) Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis. Mol Carcinog 52:94–102
38. Izumi K, Li Y, Ishiguro H, Zheng Y, Yao JL et al (2014) Expression of UDP-glucuronosyltransferase 1A in bladder cancer: association with prognosis and regulation by estrogen. Mol Carcinog 53:314–324